Bayer
€45.40Change from previous close: −5.32%Absolute change: −€2.55
At a glance
- Revenue growth
- −2.21%
- 2025 vs 2024
- Net margin
- -7.9%
- 2024: -5.5%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 45,575 | 46,606 | 47,637 | 50,739 | 44,081 |
| Cost of revenue | 18,527 | 20,831 | 19,687 | 18,886 | 17,045 |
| Gross profit | 27,048 | 25,775 | 27,950 | 31,853 | 27,036 |
| Selling, general and administrative | 16,023 | 16,764 | 16,002 | 16,036 | 14,531 |
| Research and development | 5,650 | 5,974 | 5,370 | 6,168 | 5,326 |
| Operating income | 5,113 | 3,115 | 7,035 | 9,121 | 7,475 |
| EBIT | 5,113 | 3,115 | 7,035 | 9,121 | 7,475 |
| EBITDA | 8,869 | 6,806 | 10,567 | 12,705 | 10,877 |
| Interest expense | 1,929 | 1,946 | 1,618 | 1,058 | 930 |
| Pre-tax income | -3,129 | -2,334 | -1,621 | 4,670 | 2,046 |
| Income tax | 466 | 212 | 1,321 | 504 | 1,024 |
| Net income | -3,620 | -2,552 | -2,941 | 4,150 | 1,000 |
| Net income to common shareholders | -3,620 | -2,552 | -2,941 | 4,150 | 1,000 |
| Basic EPS | -3.68 | -2.60 | -2.99 | 4.22 | 1.02 |
| Diluted EPS | -3.68 | -2.60 | -2.99 | 4.22 | 1.02 |
| Average shares (basic) | 982 | 982 | 982 | 982 | 982 |
| Average shares (diluted) | 982 | 982 | 982 | 982 | 982 |
| Dividend per share | 0.11 | 0.11 | 0.11 | 2.40 | 2.00 |